FDA Approves First Generic of ProAir HFA
February 24, 2020 -- The U.S. Food and Drug Administration today approved the first generic of ProAir HFA (albuterol sulfate) Inhalation Aerosol for the treatment or prevention of bronchospasm in patients four years of age and older with reversible...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
More News: AccuNeb | Albuterol | Food and Drug Administration (FDA) | General Medicine | Proair HFA | Ventolin